Renovaro Biosciences Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 6.50 M | $5.43 M | 79.92% | 4.15% |
| VANGUARD GROUP INC | 02/11/2025 | 5.72 M | $4.78 M | -0.01% | 3.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.33 M | $1.95 M | 48.36% | 1.49% |
| STATE STREET CORP | 02/14/2025 | 2.06 M | $1.73 M | 55.98% | 1.32% |
| NORTHERN TRUST CORP | 02/14/2025 | 889,357 | $743,058 | 49.50% | 0.57% |
| UBS GROUP AG | 02/14/2025 | 763,701 | $638,455 | 1,543.92% | 0.49% |
| MORGAN STANLEY | 02/14/2025 | 368,164 | $307,602 | 3.23% | 0.24% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 364,479 | $304,522 | 292.40% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 362,126 | $302,556 | 82.00% | 0.23% |
| JPMORGAN CHASE & CO | 02/12/2025 | 353,833 | $295,628 | 280.42% | 0.23% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 300,000 | $250,650 | 200.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 223,915 | $187,081 | 137.23% | 0.14% |
| CITIGROUP INC | 02/12/2025 | 187,517 | $156,671 | 207.34% | 0.12% |
| BARCLAYS PLC | 02/13/2025 | 179,844 | $150,000 | 158.65% | 0.11% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 151,681 | $126,729 | 128.82% | 0.10% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 127,437 | $107,047 | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 01/30/2025 | 112,960 | $94,425 | 122.56% | 0.07% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 101,573 | $85,000 | 0.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 91,745 | $76,607 | 3.82% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 75,454 | $63,042 | 100.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 64,923 | $54,243 | 174.78% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 61,726 | $51,572 | 284.78% | 0.04% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 59,101 | $49,379 | 224.93% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 57,495 | $48,037 | 114.79% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 52,500 | $44,000 | -21.29% | 0.03% |
| CITADEL ADVISORS LLC | 02/14/2025 | 49,200 | $41,107 | 1,540.00% | 0.03% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 45,797 | $38,263 | 100.00% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 45,198 | $38,000 | 183.46% | 0.03% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 37,890 | $31,657 | 0.00% | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 37,100 | $31,164 | 142.48% | 0.02% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 35,312 | $29,503 | 100.00% | 0.02% |
| PROSHARE ADVISORS LLC | 02/14/2025 | 32,570 | $27,213 | 100.00% | 0.02% |
| INVESCO LTD. | 02/13/2025 | 29,067 | $24,285 | 27.34% | 0.02% |
| 02/11/2025 | 25,695 | $21,468 | 100.00% | 0.02% | |
| MSA ADVISORS, LLC | 02/12/2025 | 25,000 | $20,888 | 0.00% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 23,743 | $19,837 | 5.72% | 0.02% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 20,707 | $17,301 | -7.08% | 0.01% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 16,895 | $14,116 | 100.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 16,768 | $14,010 | 58.59% | 0.01% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 16,100 | $13,452 | 0.00% | 0.01% |
| FMR LLC | 02/13/2025 | 15,243 | $12,736 | 277.77% | 0.01% |
| HSBC HOLDINGS PLC | 02/14/2025 | 13,471 | $11,489 | -75.59% | 0.01% |
| ABEL HALL, LLC | 01/23/2025 | 12,420 | $10,377 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 12,224 | $10,219 | -26.07% | 0.01% |
| AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 12,098 | $10,108 | 153.26% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 11,843 | $9,895 | 137.95% | 0.01% |
| CIBC WORLD MARKETS CORP | 02/10/2025 | 10,822 | $9,042 | 100.00% | 0.01% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 10,487 | $8,762 | 100.00% | 0.01% |
| JANE STREET GROUP, LLC | 02/14/2025 | 10,321 | $8,623 | -50.53% | 0.01% |
| XTX TOPCO LTD | 02/13/2025 | 10,120 | $8,455 | -47.33% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Renovaro Biosciences Inc. institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of Renovaro Biosciences Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 6.5 M
VANGUARD GROUP INC: 5.72 M
GEODE CAPITAL MANAGEMENT, LLC: 2.33 M
STATE STREET CORP: 2.06 M
NORTHERN TRUST CORP: 889,357
UBS Group AG: 763,701
14.13% of Renovaro Biosciences Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 25.71 M shares in the last 24 months. This purchase volume represents approximately $9.26 M in transactions.